TorreyPines Therapeutics engages in the discovery and development of small molecule compounds in the United States.
TorreyPines Therapeutics engages in the discovery and development of small molecule compounds in the United States.Its product portfolio includes both candidates from its drug targeting platforms and in-licensed and acquired product candidates. As of August 31, 2010, its pipeline includes three clinical development programs. It also has three other clinical-stage product candidates, for which it is seeking business development partners, and it has four preclinical product candidates it is developing, three of which are based upon its drug-targeting platforms.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Mar 17, 2005 | Series C | $34.80M | 2 | — | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Advent International | — | Series C |
Sorrento Ventures | — | Series C |